BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23835393)

  • 1. Monte Carlo characterization of 169Yb as a high-dose-rate source for brachytherapy application by FLUKA code.
    Anjomrouz M; Sadeghi M; Haddadi A
    J Appl Clin Med Phys; 2013 Jul; 14(4):4298. PubMed ID: 23835393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo characterization of a new Yb-169 high dose rate source for brachytherapy application.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Mar; 37(3):1129-36. PubMed ID: 20384248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
    Currier B; Munro JJ; Medich DC
    Med Phys; 2013 Aug; 40(8):080701. PubMed ID: 23927294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Milickovic N; Giannouli S; Baltas D
    Med Phys; 2005 Dec; 32(12):3832-42. PubMed ID: 16475783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dosimetric functions for a new
    Safaeipour E; Poorbaygi H; Jabbari I; Sheibani S
    J Appl Clin Med Phys; 2021 Sep; 22(9):82-93. PubMed ID: 34263515
    [No Abstract]   [Full Text] [Related]  

  • 13. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose rate constants for 125I, 103Pd, 192Ir and 169Yb brachytherapy sources: an EGS4 Monte Carlo study.
    Mainegra E; Capote R; López E
    Phys Med Biol; 1998 Jun; 43(6):1557-66. PubMed ID: 9651025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo Dosimetry of the 60Co BEBIG High Dose Rate for Brachytherapy.
    Campos LT; de Almeida CE
    PLoS One; 2015; 10(9):e0139032. PubMed ID: 26418559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo aided room scatter corrections in the air-kerma strength standardization of 169Yb and 60Co brachytherapy sources.
    Selvam TP; Rajan KN; Sethulakshmi P; Bhatt BC
    Phys Med Biol; 2003 Jun; 48(11):N139-47. PubMed ID: 12817945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermoluminescent and Monte Carlo dosimetry of a new 170Tm brachytherapy source.
    Nazari S; Sadeghi M; Shirvani-Arani S; Bahrami-Samani A; Saidi P
    Phys Med; 2014 Mar; 30(2):178-83. PubMed ID: 23764298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
    Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo calculated TG-60 dosimetry parameters for the beta- emitter 153Sm brachytherapy source.
    Sadeghi M; Taghdiri F; Hosseini SH; Tenreiro C
    Med Phys; 2010 Oct; 37(10):5370-5. PubMed ID: 21089772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.